Published 20:23 IST, August 3rd 2020
Russia to begin mass production of experimental COVID-19 vaccine in September
Russia plans to start mass production of potential coronavirus vaccine by September, especially of one developed at the Gamaleya institute in Moscow.
Advertisement
Russia aims to start mass production of potential coronavirus vaccine by September, especially of one developed at Gamaleya institute in Moscow. According to reports, vaccine developed at institute is currently at an vanced st and authorities are planning to start mass production of it by next month. Moscow is also pushing ahe with several or protos and is aiming to produce millions of doses by next year. Russia's industry minister while talking to press confirmed that government is expecting to start mass production by September.
Advertisement
Health Minister Mikhail Murashko on August 1 said that vaccine prepared at Gamaleya institute successfully underwent vanced clinical trials and w papers by state are being reied to get it registered. As per reports, two more vaccines are undergoing clinical trials in Russia, while one will begin human testing within two months. Scientists in Russia have controversially claimed that y will be first country to develop a COVID-19 vaccine in world, even comparing it with -race between United States and USSR, when latter sent first satellite into .
Advertisement
Controversy surrounding vaccine
According to reports, researchers and scientists working on vaccine at Gamaleya institute months ago injected proto into mselves, garnering criticism from international health community for rushing human trials. Meanwhile, United Kingdom, Cana, and United States have accused Russian hacking group linked to intelligence ncy in country of stealing important research papers related to COVID-19 vaccine. Moscow, however, has denied all those allegations as 'propaganda'. Russia is currently fourth-most affected country in world due to SARS-CoV-2, after US, Brazil, and India.
Advertisement
20:22 IST, August 3rd 2020